文献速递消化道肿瘤放疗姑息放疗与转移瘤放疗物理与技术

采用短程放疗联合接触式近距离放疗推量对老年直肠癌患者进行计划性器官保留——一项国际多中心分析

Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis.
PubMed 文献 · Clin Transl Radiat Oncol · 2023-01-11

该国际多中心分析纳入2007至2019年间5个中心258例接受短程放疗联合接触式X线近距离放疗以实现器官保留的直肠癌患者,中位年龄81岁;单纯放疗组226例和局部切除后立即放疗组32例的完全临床缓解率分别为70%和97%,局部复发率分别为16%和3%,中位生存分别为40个月和52个月,94%患者至末次随访时避免造口。

要点

  • 258例老年直肠癌患者接受短程放疗联合接触式X线近距离放疗,中位年龄81岁。
  • 单纯放疗组完全临床缓解率70%,局部切除后立即放疗组97%。
  • 单纯放疗组局部复发率16%,局部切除后立即放疗组3%;94%患者避免造口。

核心结论

  • 数据提示短程放疗联合接触式X线近距离放疗在主要为老年且合并症人群中提供良好的姑息效果并避免造口。
  • 肿瘤学结局与既往发表研究相当。
  • 需要更加关注器官保留后的生活质量结局。

研究设计与样本

  • 国际多中心分析,从Guildford结直肠数据库或当地数据库识别5个中心2007至2019年间接受短程放疗联合接触式X线近距离放疗并以器官保留为意图的258例患者。
  • 226例接受单纯放疗,32例在局部切除后立即接受放疗。
  • 分析并报告缓解与生存数据,中位随访24个月。

主要发现

  • 中位年龄81岁。
  • 单纯放疗组70%和局部切除后立即放疗组97%的患者在短程放疗联合接触式X线近距离放疗后达到完全临床缓解。
  • 达到完全临床缓解者中,单纯放疗组16%和局部切除后立即放疗组3%出现局部复发。
  • 接触式X线近距离放疗后中位生存单纯放疗组40个月,局部切除后立即放疗组52个月。
  • 94%患者至末次随访时保持无造口。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The use of external beam radiotherapy (EBRT) and contact X-Ray brachytherapy (CXB) is emerging as an effective alternative in patients with early stage rectal cancer with the intent of organ preservation (OP). Short course radiotherapy (SCRT) is an alternative EBRT schedule for patients not fit for chemotherapy or for longer courses of EBRT. There are no multicentre studies that have reported on the outcomes of SCRT with a CXB boost, therefore we present these from patients from centres from the UK and Sweden. MATERIALS AND METHODS: From the Guildford Colorectal Database or local databases, 258 patients who underwent SCRT and CXB with the intent of OP from five centres treated between 2007 and 2019 were identified. Response and survival data was analysed and presented. RESULTS: With a median age of 81, 226 patients were treated with radiotherapy alone (RTA) and 32 immediately after local excision (ILE). Median follow-up was 24 months. 70% and 97% of patients in the RTA and ILE groups respectively had a complete clinical response (cCR) after SCRT with CXB. Of those, local relapse was seen in 16% of the RTA and 3% of the ILE group. Median survival was 40 months after CXB in the RTA and 52 months in the ILE group. 94% of patients remained stoma-free to the point of latest follow-up. CONCLUSION: This data suggests that CXB when combined with SCRT, in a mainly elderly and comorbid population, provides good palliation with stoma-avoidance. Oncological outcomes compare with previously published work. A greater focus is required on quality of life outcomes after OP.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Steinke J, Jordan C, Rossides S, et al. Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis. Clin Transl Radiat Oncol. 2023. PMID: 36686563. doi:10.1016/j.ctro.2023.100580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。